Literature DB >> 23443820

WAIS-IV profile of cognition in schizophrenia.

Natalie M Michel1, Joel O Goldberg, R Walter Heinrichs, Ashley A Miles, Narmeen Ammari, Stephanie McDermid Vaz.   

Abstract

The Wechsler Adult Intelligence Scale (WAIS) has been used extensively to study impairment across a range of cognitive domains in schizophrenia. However, cognitive performance among those with the illness has yet to be examined using the newest edition of this measure. Hence, the current study aims first, to provide WAIS-IV normative data for Canadian individuals with schizophrenia of low average intelligence; second, to examine schizophrenia performance on all WAIS-IV subtest, index and general intelligence scores relative to healthy comparison subjects; and third, to revalidate the pattern of impairment identified in this clinical group using the WAIS-III, where processing speed (PS) was most affected, followed by working memory (WM), perceptual reasoning (PR) and verbal comprehension (VC). The WAIS-IV was administered to outpatients with schizophrenia and their performance compared with age, gender, and education matched controls. WAIS-IV schizophrenia performance data are provided. Analyses revealed significant impairment on several tasks, including the new Cancellation subtest and the VC supplemental subtest, Comprehension. At the index score level, group differences in PS were significantly larger than those observed in all other cognitive domains. Impairments were also observed in WM amid relatively preserved performance in VC, thereby confirming the pattern of impairment identified using the WAIS-III.

Entities:  

Keywords:  Wechsler Adult Intelligence Scale; cancellation; cognition; processing speed; schizophrenia; verbal comprehension; working memory

Mesh:

Year:  2013        PMID: 23443820     DOI: 10.1177/1073191113478153

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  5 in total

1.  The Screen for Cognitive Impairment in Psychiatry: Proposal for a polytomous scoring system.

Authors:  Juana Gómez-Benito; Ángela I Berrío; Georgina Guilera; Emilio Rojo; Scot Purdon; Oscar Pino
Journal:  Int J Methods Psychiatr Res       Date:  2017-11-07       Impact factor: 4.035

2.  Advanced glycation end products and cognitive impairment in schizophrenia.

Authors:  Akiko Kobori; Mitsuhiro Miyashita; Yasuhiro Miyano; Kazuhiro Suzuki; Kazuya Toriumi; Kazuhiro Niizato; Kenichi Oshima; Atsushi Imai; Yukihiro Nagase; Akane Yoshikawa; Yasue Horiuchi; Syudo Yamasaki; Atsushi Nishida; Satoshi Usami; Shunya Takizawa; Masanari Itokawa; Heii Arai; Makoto Arai
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

3.  Feasibility of a web-based neurocognitive battery for assessing cognitive function in critical illness survivors.

Authors:  Kimia Honarmand; Sabhyata Malik; Conor Wild; Laura E Gonzalez-Lara; Christopher W McIntyre; Adrian M Owen; Marat Slessarev
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

4.  The Relationship of Functional Status of Cortisol, Testosterone, and Parameters of Metabolic Syndrome in Male Schizophrenics.

Authors:  Yi Han; Haifeng Ji; Li Liu; Yuncheng Zhu; Xixi Jiang
Journal:  Biomed Res Int       Date:  2020-10-22       Impact factor: 3.411

5.  Psychotically driven aggression is associated with greater mentalizing challenges in psychotic spectrum disorders.

Authors:  Anette Gm Johansson; Malin Källman; Lennart Högman; Marianne Kristiansson; Håkan Fischer; Sven Bölte
Journal:  BMC Psychiatry       Date:  2020-09-29       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.